Table 2 Summary of the Quality-of-Life Results
Subscales | WLC | 21-day MPRRI | Pre to 6-month between-group change 21Â day-MPRRI with WLC | ||||
|---|---|---|---|---|---|---|---|
Baseline (n = 259) | 6-month (n = 248) | Baseline (n = 129) | 6-month (n = 109) | ∆ (95% CI) | P | ES | |
Global health status | 61.1 ± 22.7 | 63.3 ± 23.2 | 58.2 ± 22.8 | 66.7 ± 19.9 | 3.8 (− 1.3, 9.0) | 0.1437 | 0.2720 |
Physical functioning | 82.7 ± 12.8 | 80.2 ± 15.4 | 78.9 ± 15.0 | 80.8 ± 13.0 | 3.1 (0.3, 6.4) | 0.0332 | 0.3628 |
Emotional functioning | 84.9 ± 17.1 | 82.3 ± 19.3 | 77.1 ± 22.7 | 83.5 ± 16.4 | 6.0 (2.5, 9.5) | 0.0009 | 0.5794 |
Cognitive functioning | 84.4 ± 16.2 | 81.4 ± 16.3 | 74.2 ± 19.4 | 79.7 ± 18.8 | 3.5 (0.1, 6.9) | 0.0443 | 0.5297 |
Pain | 12.9 ± 15.7 | 15.3 ± 17.9 | 19.9 ± 22.4 | 12.3 ± 14.5 | − 6.0 (− 9.7, − 2.3) | 0.0015 | 0.5171 |
Insomnia | 19.6 ± 24.1 | 24.0 ± 26.3 | 26.4 ± 29.7 | 22.5 ± 28.8 | − 5.3 (− 10.2, − 0.4) | 0.0346 | 0.3011 |